Microtide Biotechnology
Shanghai
About Microtide Biotechnology
Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomes and redefine the future of regenerative medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $14.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2026)
Canonical: https://fsome.com/organization/microtide-biotechnology-126086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.